I could blame lack of critical thinking however I see non prescribing health care providers elaborating eloquently on these topics
The GLP-1 medication semaglutide reduces strokes, heart attacks, and death from heart attacks by 20%
Potassium bicarbonate is strategically added to stabilize the active ingredient, prevent oxidation and improve flavour
Note: Tirzepatide is the only one of these medications that is both a GLP-1 and GIP agonist
In both comparisons, adults taking GLP-1 drugs were associated with a significantly higher risk of hair loss, more specifically, 37 percent higher compared to SGLT-2 inhibitors and 68 percent higher than DPP-4 inhibitors
Mounjaro was tested over 72 weeks with the following results: Those taking 5mg lost 16% of their starting weight Those taking 10mg lost 21.4% of their starting weight Those taking 15mg lost 22.5% of their starting weight Wegovy was tested over 68 weeks with people losing 15% or more of their starting weight at the maintenance dose of 2.4mg